Source: journal of glaucoma. Unidade: FM
Subjects: GLAUCOMA (TERAPIA), HIPERTENSÃO OCULAR (TERAPIA), SEGUIMENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HATANAKA, Marcelo et al. An eigth-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure. journal of glaucoma, v. 17, n. 8, p. 674-679, 2008Tradução . . Acesso em: 19 fev. 2026.APA
Hatanaka, M., Grigera, D. E., Barbosa, W. L., Jordão, M., & Susanna Júnior, R. (2008). An eigth-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure. journal of glaucoma, 17( 8), 674-679.NLM
Hatanaka M, Grigera DE, Barbosa WL, Jordão M, Susanna Júnior R. An eigth-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure. journal of glaucoma. 2008 ; 17( 8): 674-679.[citado 2026 fev. 19 ]Vancouver
Hatanaka M, Grigera DE, Barbosa WL, Jordão M, Susanna Júnior R. An eigth-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure. journal of glaucoma. 2008 ; 17( 8): 674-679.[citado 2026 fev. 19 ]
